Investors & News

Analyst Coverage

Firm Analyst
Bank of America/Merrill Lynch   Gregg Gilbert
Canaccord Genuity   Randall Stanicky
Deutsche Bank   David M. Steinberg
JP Morgan   Jessica Fye
Ladenberg Thalmann   Matt Kaplan
Lazard Capital Markets   William Tanner, Ph.D
Leerink Swann   Joseph P. Schwartz
Wedbush Pac Grow Life Sciences   Liana Moussatos, Ph.D.

MAP Pharmaceuticals, Inc. is followed by the analyst(s) listed above. Please note that any opinions, estimates or forecasts regarding MAP Pharmaceuticals, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of MAP Pharmaceuticals, Inc. or its management. MAP Pharmaceuticals, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

 

 

Stock Quote
(NASDAQ:MAPP)

Price:
15.77
Change:
- 0.36
Day High:
16.17
Day Low:
15.77
Volume:
84,700
3:32 PM ET on Feb 22, 2012
Delayed at least 20 minutes.
Provided by eSignal.

Shareholder Tools